Biologics Manufacturing 5.0

Biologics Manufacturing 5.0 2024, is a part of the Biologics Manufacturing World Series with a focus on AI and digitalization's profound impact on bioprocessing.

With a decade of successful operations, the Biologics Manufacturing World Series has firmly established itself as a prominent player in the industry. At the forefront of this series, is a conference poised to redefine the future of biopharmaceutical manufacturing. In an era where the convergence of cutting-edge technologies, AI and digitalization are reshaping industries, we bring together global biopharmas to explore the transformative potential of Industry 5.0 in Biologics Manufacturing.

Our conference agenda delves into crucial topics including the application of Industry 5.0 in Bio-manufacturing, real-time modeling in commercial production, and cloud-based collaboration. We also explore alternatives to CHO systems and strategies for contamination risk reduction. Additionally, we discuss achieving successful tech transfer, converting bioprocess scaling challenges into opportunities, and addressing obstacles in continuous and integrated processing.

Immerse in a 3-day intimate conference uniting pharma, biotech, and academia leaders to delve into Bioprocessing and Smart Manufacturing. Explore 36 dynamic topics in Roundtables, Panel Discussions, and presentations. Our facilitator-led masterclasses offer practical teaching, including case studies and individual challenge discussions.